Mark Willem Ledeboer

This inventor holds 53 USPTO granted patents and 18 published patent applications, plus 3 CIPO patents and 15 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Vertex Pharmaceuticals, Inc., Goldfinch Bio, Inc., Gfb (Abc), LLC. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Willem Ledeboer. Retrieved from https://idiyas.com/inventor/mark-willem-ledeboer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53 (Patent Applications = 18)

% Patents Active = 58.5

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 15 (Patent Applications = 26)

Average Co-Inventor Count = 8.9

ph-index = 18

Forward Citations = 938(Granted Patents)

Forward Citations (Not Self Cited) = 713(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Acton, MA (US) (2003 - 2023)
Boston, MA (US) (2021 - 2023)

Company Filing History:

48 out of 1,167

Vertex Pharmaceuticals, Inc.

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

DNA-PK Inhibitors

Influenza Virus Inhibitors

JAK2 Inhibitors

Pyridazinones

Imidazodiazepinediones

Pteridinone Compounds

Protein Kinase Inhibitors

Phosphatidylinositol 3-Kinase

Pyrazolo[1,5-a]pyrimidines

Deazapurines

Aminotriazole Compounds

Substituted Pyrrolo[2,3-d]pyrimidines

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466834 - Imidazodiazepinediones and methods of use thereof (2025-11-11),

2. 12435078 - Pyridazinones and methods of use thereof (2025-10-07),

3. 12384790 - Pteridinone compounds and uses thereof (2025-08-12),

4. 11623930 - Imidazodiazepinediones and methods of use thereof (2023-04-11),

5. 11572364 - Pteridinone compounds and uses thereof (2023-02-07),

6. 11059826 - Pteridinone compounds and uses thereof (2021-07-13),

7. 11046690 - Pyridazinones and methods of use thereof (2021-06-29),

8. 11021465 - DNA-PK inhibitors (2021-06-01),

9. 11008305 - DNA-PK inhibitors (2021-05-18),

10. 10875855 - Inhibitors of influenza viruses replication (2020-12-29),

11. 10874673 - Inhibitors of influenza viruses replication (2020-12-29),

12. 10654850 - Pyridazinones and methods of use thereof (2020-05-19),

13. 10501439 - DNA-PK inhibitors (2019-12-10),

14. 10442791 - DNA-PK inhibitors (2019-10-15),

15. 10391095 - DNA-PK inhibitors (2019-08-27),

Title: The Innovative Journey of Mark Willem Ledeboer

Introduction:

Mark Willem Ledeboer, a talented inventor based in Acton, MA (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Mark Willem Ledeboer holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights:

Throughout his illustrious career, Mark Willem Ledeboer has demonstrated a keen ability to identify gaps in the market and develop innovative products that meet the needs of consumers. His dedication to pushing the boundaries of technology has earned him recognition as a visionary inventor.

Collaborations:

Mark Willem Ledeboer has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Mark Willem Ledeboer's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions have not only transformed industries but have also inspired future generations of inventors to think outside the box.

Profile summary based on public USPTO records.